We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
349 hedge funds and large institutions have $2.25B invested in Ginkgo Bioworks in 2023 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 139 increasing their positions, 58 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
235% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 17
140% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 58
11% more funds holding
Funds holding: 315 → 349 (+34)
2% more call options, than puts
Call options by funds: $7.89M | Put options by funds: $7.78M
0.03% more ownership
Funds ownership: 1.91% → 1.94% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less capital invested
Capital invested by funds: $2.25B → $2.25B (-$5.07M)
Holders
349
Holders Change
+34
Holders Change %
+10.79%
% of All Funds
5.54%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
57
Increased
139
Reduced
58
Closed
17
Calls
$7.89M
Puts
$7.78M
Net Calls
+$119K
Net Calls Change
+$1.73M
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$24.9M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$15.9M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$15.9M |
| 4 |
WF
Welch & Forbes
Boston,
Massachusetts
|
+$14M |
| 5 |
BlackRock
New York
|
+$8.99M |
